BG
NRIX icon

Bellevue Group’s Nurix Therapeutics NRIX Stock Holding History

Bellevue Group’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,000
Closed -$151K – 159
2024
Q4 		$151K Hold
8,000
– – ﹤0.01% 149
2024
Q3 		$180K Buy
+8,000
New +$180K ﹤0.01% 149